Quick Answer
Aclaris Therapeutics, Inc. reported Gross Profit of $3.24 million for fiscal year 2018.
Aclaris Therapeutics, Inc. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2018 | $3.24M | +580.9% |
| 2017 | $476.0K | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2018 | $435.0K | +88.3% | -82.6% |
| June 30, 2018 | $2.50M | — | +1552.3% |
| March 31, 2018 | $151.0K | — | -34.6% |
| September 30, 2017 | $231.0K | — | — |
- Aclaris Therapeutics, Inc. showed an increase of +580.9% in Gross Profit compared to the prior fiscal year.
- Over the 2017–2018 period, Aclaris Therapeutics, Inc.’s gross profit has grown by 580.9% (from $476.0 thousand to $3.24 million).
- The most recent figure is from Aclaris Therapeutics, Inc.’s fiscal year 2018 report (Form 10-K), filed with the SEC on March 18, 2019.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: